A newly released survey conducted by HealthPrize Technologies, an industry-leading medication adherence and digital patient engagement company, shows that physicians recognize medication adherence as an extremely important factor in clinical outcomes for patients with chronic conditions.

Survey results showed that while co-pay discount programs sponsored by pharmaceutical companies are important in promoting adherence, rewards programs rank equally in the minds of physicians.

Survey respondents were also asked about various interventions designed to improve adherence rates and improve clinical outcomes. While education ranked low on the list, the two solutions ranked highest were rewards (40%) and co-pay discounts (39%). Furthermore, a combined 72% of physicians responded that they would, or might, be more likely to prescribe a medication brand that offered an innovative adherence service over others in the same class, assuming similar cost and side effect profile.